Is BristolMyers Squibb stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, BristolMyers Squibb pays dividends. Last time was Friday 1st of November 2024 where the investors holding the stock on Friday 4th of October 2024 were paid $0.6 per share. Over the last 210 times between 1972 and 2024, BristolMyers Squibb has paid $89.2304 with an average of $0.42 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for BristolMyers Squibb 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $56.45, you would have made a profit of $1.430 per share or 2.53%
Yes, the average daily trading liquidity for BristolMyers Squibb is $11.00 million. You should therefore be able to get in and out of your positions relatively fast.
BristolMyers Squibb has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.30, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for BristolMyers Squibb to be high [0.75 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.